Home › Funds › Artia Global Partners LP › ASND

Artia Global Partners LP position in ASND

ASCENDIS PHARMA A/S · Health Care

Artia Global Partners LP reported holding 17,740 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$4.7M, representing 0.87% of its reported portfolio and ranking #27 among its reported holdings. Artia Global Partners LP has disclosed ASND holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)17.74K sh
Reported value held$4.73M
Portfolio Weight0.87%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's ASND position evolved

Artia Global Partners LP first disclosed a stake in ASND in Q1 2024 at 15,894 shares (US$2.4M). The position peaked in Q2 2026 at 17,740 shares, worth US$4.7M. Across 10 filings, Artia Global Partners LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 17,740 shares valued at US$4.7M. Notable position changes include a 53% trim in Q2 2024 (shares rose 9% over the following quarter), a 65% increase in Q2 2025 (shares rose 15% over the following quarter), a 45% increase in Q4 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 15.89K $2.40M New
Q2 2024 7.44K $1.01M Reduce
Q3 2024 7.44K $1.11M Hold
Q4 2024 7.44K $1.02M Hold
Q1 2025 7.44K $1.16M Hold
Q2 2025 12.24K $2.11M Add
Q3 2025 12.24K $2.43M Hold
Q4 2025 17.74K $3.78M Add
Q1 2026 17.74K $4.06M Hold
Q2 2026 17.74K $4.73M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Artia Global Partners LP held ASND?

Artia Global Partners LP has disclosed ASND holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Artia Global Partners LP's current position in ASND?

As of Q2 2026, Artia Global Partners LP holds 17.74K shares of ASND (ASCENDIS PHARMA A/S), valued at $4.73M, representing 0.87% of its reported portfolio and ranking #27.

Has Artia Global Partners LP been buying or selling ASND?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in ASND. The position peaked in Q2 2026 at 17.74K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.